A method and kit are provided for measuring and monitoring a combined effect of an
anticoagulant drug on coagulation factors II and X in a patient taking the
anticoagulant drug. The method includes adding one or more coagulation reagents with the
factor VII to a
test sample and determining blood clotability of the
test sample by measuring an influence of factors II and X.